Veraxa Biotech Announces Initial Positive Results from Research Collaboration with Secarna Pharmaceuticals

Filing content

Veraxa Biotech announced initial positive results from its strategic research collaboration with Secarna Pharmaceuticals, demonstrating successful in vitro proof-of-concept for next-generation antibody oligonucleotide conjugates (AOCs).